|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.440 CNY | +0.16% |
|
-2.87% | -10.80% |
| Dec. 01 | Shanghai Raas Co., Ltd. Proposes Cash Dividend for the Third Quarter of 2025 | CI |
| Nov. 05 | Shanghai RAAS Blood Products Gets Trial Approval for Blood Clotting Disorder | MT |
| Capitalization | 42.53B 6.03B 5.14B 4.8B 4.51B 8.31B 546B 9.08B 56B 21.72B 257B 22.62B 22.14B 939B | P/E ratio 2025 * |
20.1x | P/E ratio 2026 * | 16.9x |
|---|---|---|---|---|---|
| Enterprise value | 36.26B 5.14B 4.38B 4.09B 3.85B 7.08B 465B 7.74B 47.73B 18.52B 219B 19.28B 18.88B 800B | EV / Sales 2025 * |
4.56x | EV / Sales 2026 * | 4.2x |
| Free-Float |
69.51% | Yield 2025 * |
0.62% | Yield 2026 * | 0.7% |
| 1 day | +0.16% | ||
| 1 week | -2.87% | ||
| Current month | -2.87% | ||
| 1 month | -7.07% | ||
| 3 months | -5.71% | ||
| 6 months | -7.34% | ||
| Current year | -10.80% |
| 1 week | 6.4 |  | 6.64 |
| 1 month | 6.4 | | 6.94 |
| Current year | 6.4 | | 7.3 |
| 1 year | 6.4 | | 7.53 |
| 3 years | 5.59 | | 8.68 |
| 5 years | 4.98 | | 8.68 |
| 10 years | 4.98 | | 23.88 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jun Xu
CEO | Chief Executive Officer | 61 | - |
Le Qi Chen
DFI | Director of Finance/CFO | 38 | 2021-10-25 |
Hong Qiu
IRC | Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Wei Bing Hu
BRD | Director/Board Member | 61 | 2020-05-20 |
Li Xia Tan
CHM | Chairman | 55 | 2024-07-29 |
Jun Xu
CHM | Chairman | 61 | - |
| Name | Weight | AuM | Varia. Jan 1. | Investor |
|---|---|---|---|---|
 | 0.69% | 0 M€ | -19.71% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.16% | -2.87% | -16.58% | +10.27% | 6.03B | |
| -0.74% | +3.19% | +0.04% | -0.16% | 76.06B | |
| +2.86% | -0.09% | -33.92% | -38.32% | 58.96B | |
| +1.38% | +69.20% | +69.20% | +69.20% | 53.01B | |
| -2.24% | -4.93% | +29.50% | +225.99% | 52.48B | |
| +0.93% | -3.97% | +12.08% | -40.09% | 25.54B | |
| +1.85% | -7.39% | +123.62% | +166.25% | 18.76B | |
| -0.72% | -6.94% | +34.70% | +15.85% | 18.73B | |
| -4.52% | -5.15% | +38.56% | +1,015.98% | 15.67B | |
| +1.46% | +2.05% | +171.59% | +723.11% | 14.48B | |
| Average | +0.04% | -2.24% | +42.88% | +214.81% | 33.97B | |
| Weighted average by Cap. | +0.19% | -0.76% | +27.93% | +123.94% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 7.96B 1.13B 961M 897M 844M 1.55B 102B 1.7B 10.48B 4.06B 48.15B 4.23B 4.14B 176B | 8.76B 1.24B 1.06B 988M 929M 1.71B 112B 1.87B 11.53B 4.47B 52.98B 4.66B 4.56B 193B |
| Net income | 2.12B 301M 256M 239M 225M 414M 27.24B 453M 2.79B 1.08B 12.84B 1.13B 1.1B 46.84B | 2.51B 356M 303M 283M 266M 491M 32.24B 536M 3.31B 1.28B 15.2B 1.34B 1.31B 55.44B |
| Net Debt | -6.28B -890M -758M -708M -666M -1.23B -80.6B -1.34B -8.27B -3.21B -37.99B -3.34B -3.27B -139B | -5.75B -815M -694M -649M -610M -1.12B -73.82B -1.23B -7.57B -2.94B -34.8B -3.06B -2.99B -127B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-12-12 | 6.440 ¥ | +0.16% | 34,442,530 |
| 25-12-11 | 6.430 ¥ | -0.77% | 21,290,660 |
| 25-12-10 | 6.480 ¥ | -0.92% | 29,495,900 |
| 25-12-09 | 6.540 ¥ | -1.21% | 29,539,520 |
| 25-12-08 | 6.620 ¥ | -0.15% | 19,383,420 |
End-of-day quote Shenzhen S.E., December 11, 2025
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 002252 Stock
Select your edition
All financial news and data tailored to specific country editions
